Research Archivi - Pagina 2 di 4

2 gennaio 2024

Analytical Standards Industry is Led by North America

The analytical standards market was USD 1,618.9 million in 2023, which will increase to USD 2,588.1 million, powering at a 7.0% compound annual growth rate, by 2030.

This progression is because of the increasing application of the related products in biotechnology, pharmaceutical, food quality & safety assurance, forensics, environmental analysis, and various other areas.

Furthermore, their increasing use in the clinical study of complete metabolites and proteins in an organism or a cell, with the surging worry to monitor or control pollution, boosts this growth.

Moreover, the growing worry about product expiry analysis and food quality & safety, owing to the strict government guidelines in this regard, is boosting the acceptance of analytical standards.

In 2023, the environmental science category, based on application, accounted for a 20% share, and it will continue this trend during this decade. This can be because of the increasing worries owing to the rising pollutants emissions and growing efforts for an effective waste processing and clean environment.

North America led the industry, and it will remain leading, advancing at a 7.2% CAGR, till 2030. This is because of the high R&D spending by pharmaceutical firms and the existence of most global manufacturers and regulatory bodies, who have laid down stringent quality standards to fulfill by pharmaceutical businesses.

Furthermore, the advancing biotechnology sector and consequently rising application of analytical standards and technologies also assist this regional growth.

In addition, the existence of key manufacturers has resulted in the high sale of standards or reference compounds to the chemical and pharmaceutical sectors in this continent.

It is because of the growing concerns regarding the safety as well as the quality of food, the analytical standards industry will advance continuously in the coming years.

21 dicembre 2023

NAT Category To Show the Fastest Growth in the Blood Screening Industry

The blood screening market is on the way of growth, and this trend will continue in the years to come as well. The major factors powering the industry are the enhancements in the blood screening technology, strict regulations with regards to contaminated blood, increased spending, and high incidence of chronic, respiratory, and infectious diseases.

The reagents and kits category dominated the industry in the past. This was because of the need for these products throughout the first stage of the blood screening process and easy obtainability of numerous reagents. Also, the high preference for reliable, fast, specific detection of TTD also powered the acceptance of these products.

The NAT category will have the fastest growth in the years to come. This has a lot to do with the fact that is it is very popular among testing labs and blood banks, because of its higher sensitivity as opposed to the others.

Get the sample Copy of this report: https://www.psmarketresearch.com/market-analysis/blood-screening-market/report-sample

In the past, blood banks had the major share, as a result of the increasing count of organ transplant surgeries and blood donation activities. Furthermore, the increasing consciousness with regards to the dangers of contaminated blood increased the growth of this category.

North America had the highest revenue in the blood screening market in the past, as a result of the high frequency of respiratory and infectious diseases in the region. For example, the region had the highest number of COVID-19 cases and deaths till April 13, 2020.

Furthermore, the introduction of novel products by the players operating in the industry, chiefly for COVID testing, such as the CoronaCheck antibody test kit by BioResponse, is also has an important role in the growth of the industry.

Also, the growing government support with regards to the use of advanced screening products is also a main growth driver of the regional industry.

Increasing count of collaborations and mergers among the important players has turned out to be a prominent trend in the industry.

For example, in January 2020, Illumina Inc. and F. Hoffmann-La Roche Ltd. started a fifteen-year, non-exclusive partnership to boost the use of distributable (NGS)- based oncology testing.

Similarly, in April 2019, Ortho-Clinical Diagnostics Inc. introduced its D-Dimer assay under its MicroTip partnership assay program. This was developed by the corporation in collaboration with Diazyme Laboratories Inc.

The increasing number of chronic cases all over the globe, and the growing count of blood donors are the two factors among the many which has helped in the growing demand for blood screening. This demand will only go up from here in the years to come as well.

20 dicembre 2023

External Defibrillator – Global Industry Development and Future Analysis

The external defibrillator market is witnessing growth and is projected to reach USD 8,709.2 million by 2030, growing at a CAGR of 8.7% during the projection period. This is because of the rising elderly populace and growing cases of out-of-hospital cardiac arrest.

As per the AHA Heart & Stroke Statistics report in recent years, there are over 356,461 OHCA cases stated per annum in the U.S., with around 90% of them causing the patient’s demise. Additionally, in adults, the most often place of OHCA is a residence 73.9%, a public environment 15.1%, or a nursing home 10.9%.

The Indian industry is projected to advance at a substantial pace during the projection period. The industry is mainly propelled by numerous measures taken by private and public establishments to increase knowledge regarding such devices, the surge in healthcare spending, and strategic growth among key companies.

Furthermore, as per the India Brand Equity Foundation, the Indian government is projected to surge healthcare expenditure to approximately 3% of its gross domestic product in 2022. This specifies that healthcare amenities are accepting technical improvements, thus propelling the external defibrillator industry in the nation.

In recent years, external defibrillators utilized for adult patients are responsible for more than 90% of the revenue share. With the growing count of adult patients in contrast to pediatric patients throughout the globe, the danger of CVDs is growing. Adults are more disposed toward cardiac illnesses because of unhealthy lifestyles.

Furthermore, as age surges, the immune system of people initiates confronting issues while fighting illnesses. Furthermore, per annum, around 0.1% of the U.S. populace witness a medicinal services-assessed, OHCA. The European continent has a similar incidence of vacillating from 0.04% to 0.1% of the populace.

In recent years, the public access settings category led the external defibrillator market, with over 30% revenue share. The growth in the occurrence of SCAs and the essential obtainability of automated external defibrillators in public access situations are major reasons paying to the development of the industry in this end-user category.

For instance, the U.S., and also a count of APAC and European nations, has established lawmaking needing the installation of such devices in public places.

In recent years, the North American region had the major revenue share, of approximately 60%, in the industry. The industry in North America is primarily boosted by the increasing healthcare expenditure, growing occurrence of CVDs, rising elderly populace, and rising knowledge regarding the advantages of external defibrillators in the event of VF and pulseless ventricular tachycardia.

Hence, the key external defibrillator industry boosters are the surging elderly populace and growing cases of cardiac illnesses.

13 dicembre 2023

North America is dominating the Life Science Analytics Industry

The global life science analytics market is witnessing growth and is projected to reach USD 18,386.0 million by 2030. This growth can be ascribed to the increasing importance of the initial discovery of illnesses with the study of present information, which can aid in understanding medicine and treatment patterns through the patient’s healthcare drive and attaining effective excellence.

In recent years, the descriptive category led the industry with a share of approximately 36%, credited to the capability of descriptive analytics to classify trends and relations, by reviewing present and historical information. It is measured in the simplest arrangement of information analysis as it defines trends and relations.

Service demand will experience the highest CAGR, mainly because of the presence of a huge count of multinationals catering to life sciences establishments, like Oracle, IBM, and Accenture. They provide a full variety of facilities in consulting, strategy, technology, and operations, which aid in delivering more-modified healthcare and better patient results.

The Asia-Pacific region is projected to experience the highest development rate in the life science analytics industry, touching 9.9% during the projection period. This development is propelled by the growing occurrence of chronic illnesses, the growth of the life sciences industry, higher acceptance of progressive technologies, and key players’ efforts to create a sturdier existence in developing Asian nations.

Moreover, expenditure in regional industries, financial development in China and India, and enhancements in healthcare infrastructure are contributing to the industry’s development in Asia-Pacific.

During the projection period, R&D is estimated to have the highest CAGR. This is because businesses are growing their expenditure in research and development to spot patterns early and strive for real-world results via data analytics. Life sciences businesses are shifting their emphasis from patient care to patient result management and prevention scenarios.

Hence, the market for life science analytics solutions is propelled by the increasing emphasis on understanding treatment and prescription patterns, growing chronic illness occurrence, and growing medication R&D activities.

4 dicembre 2023

Why Will Proton Therapy Rule the Particle Therapy Industry?

The global particle therapy market is experiencing growth and is projected to reach USD 1,634.4 million by 2030. This development can be attributed to the high acceptance of particle treatment for cancer treatment armed with the rise in the count of particle therapy centers throughout the globe.

In recent years, proton therapy dominated the industry with a revenue share of above 90%, and the category is also estimated to experience a higher CAGR, of around 8.5%, in the projection period. This development can be credited to the high acceptance of this treatment for treating numerous cancers, like brain tumors, pediatric cancer, and breast cancer.

According to a government agency, above 2 million females were identified with breast cancer in 2020 throughout the globe, making it the most prevalent cancer. Products, like synchrotrons, cyclotrons, and synchrocyclotrons, hold over 80% of the industry share, credited to the increasing acceptance of cyclotrons in numerous hospitals armed with numerous benefits provided by them like low prices. Furthermore, the increasing shift toward nuclear scans for analysis, and the accessibility of technically progressive diagnostic devices also propel the industry development in this category.

During the projection period, the single-room systems category is projected to experience a higher CAGR, of approximately 9%, because of the low price per treatment and lower development price of a single-room facility. For example, according to a government source, the price of a single-room facility is approximately USD 30 million, which is relatively very high in the case of a multi-room capacity that can price approximately USD 100 million.

In recent years, pediatric cancer accounted for over 25% of the particle therapy market share, and the category is estimated to witness the fastest development, growing at a CAGR of approximately 9.0%, in the projection period, credited to its high occurrence throughout the world. Particle treatment is typically utilized in the treatment of pediatric patients because of the high mitosis rate in kids, which needs treatment that straight targets the tumor with very less long-term side effects. It offers high accuracy and radiation control with nearly no exposure to normal body cells.

In recent years, the European particle therapy industry generated the highest revenue share. Moreover, the regional industry is projected to witness the highest CAGR, of approximately 9%, in the projection period, because of the increasing count of particle therapy amenities offering clinical processes in the region. For example, above 50% of the particle therapy centers exist in Europe.

This is due to the supportive government guidelines and the existence of technologically progressive solutions for illness diagnosis. Furthermore, the existence of a huge count of distribution platforms also boosts the industry development in the region.

28 novembre 2023

Biologics CDMO Secondary Packaging Industry Will Grow Fastest in Asia-Pacific

The biologics CDMO secondary packaging market will touch USD 3,622.6 million by 2030, powering at a rate of 8.7% by the end of this decade. This growth is credited to the snowballing drug production, the increasing pharma industry, and the growing prevalence of numerous diseases, such as chronic ailments, infectious ailments, and genetic diseases.

Boxes were the largest category in the industry, with about USD 1 billion revenue, in 2021, and they will continue dominations in the years as well.

Boxes are designed explicitly for the transport of biological products, such as frozen and controlled ambient biologics. They also provide the perfect balance between temperature control and payloads.

North America had the largest revenue share, more than 40%, in the biologics CDMO secondary packaging market. This is because of the increasing outsourcing of drug research and development and production activities by major biopharma players.

Numerous companies wish to team up with competent packing providers providing non-conventional packing solutions and have the vital capabilities to formulate exclusive packing designs in a time and cost-effective manner.

Instead, the APAC will have the fastest growth in the years to come. This growth has a lot to do with the increasing prevalence of chronic ailments, the growing emphasis of businesses on contract manufacturing, and key players are keenly interested in facility developments in the Asia Pacific region.

Furthermore, the growth of the European region will be moderate in nature in the years to come. This can be mainly as a result of the increasing requirement for biologic products, for instance vaccines, driving the research and development spending of the pharma companies.

Due to the increased production of drugs all over the world, the demand for biologics CDMO secondary packaging is on the rise, and this trend will continue in the years to come as well.

16 novembre 2023

Heart Pump Devices Industry is Powered by the Increasing Elderly Population

The heart pump devices market will grow at a rate of 22.1% by the end of this decade, to touch USD 10,912.6 million by 2030. This is because of the rising cardiovascular ailment incidence, growing elderly population, and numerous novel product introductions by market players.

On the basis of the product, VADs has the largest share, of about 70%, on account of the growing rate of tech progressions in these products by the industry players and the unreachability of organ donors. The vital drivers are the increasing number of patients suffering from heart failure and the long waiting for surgeries.

On the basis of type, the implanted category has a larger share. This is as a result of the improved eminence of life and longer survival post heart transplant these alternatives offer and the launches of the product by players.

The BTT category will have the fastest growth in the years to come. This is because of the increasing consciousness of transplantation and the obtainability of LVADs for bridge-to-transplant procedures.

North America heart pump devices market had the largest share, of around 45%, in 2022. This is because of the increasing requirement for tech advanced cardiac assist devices because of the snowballing prevalence of cardiovascular ailments. In Canada, as per the government statistics, heart disease is the second- foremost cause of death post cancer, with about 67,400 people in the country dying because of these issues in 2020.

It is because of the growing elderly population all over the world, the demand for heart pump devices will continue to increase in the years to come.

8 novembre 2023

Wound Care is Important, here is Why?

Talking about wound care, there are a few things, about which you should think about. These are, which area is injured, how much time will the wound take to recover, along with the best wound care plan for preventing them from growing worse.

When a wound is properly diagnosed, it has to be figured out that what will be the best treatment for the healing of the same. While the wound id in the process of healing, wound care plays an important part. This is because of the fact that various infections can appear if proper wound care is not administered.

Why it is Important to Care for the Wound?

If the wound id to be healed in a proper manner, proper wound care can be termed as an initial step for this. An open wound can pose the risk of infection, also resulting in scarring, amputation, and sometimes even death.

whether the wound is a result of a surgery, traumatic injury, burns, or another chronic illness, the right medication is the need of the hour to ensure the best possible healing.

The goal of the wound care is ensuring proper blood flow to the site of the wound. It is also significant for managing pain and infections.

This can be done by gentle, but thorough cleaning. After that some, topical medications can be applied, and then a sterile dressing. All this comes good for keeping the wound clean and lets it to heal quicker, while reducing the chances of any complications.

Browse detailed report analysis on Wound Care Industry Development and Demand Forecast to 2030

Prevention of an Ailment

For preventing a disease, which is contracted from an open wound, there is a requirement of monitoring the dressing of the wounds constantly. This decreases the risk of infection considerably.

Medical professionals can always advise you about changing the dressings and taking a note of the condition of the wound. They might also look at things like bleeding, temperature and smell to discover what nis happening with the wound

Wounds should be cleaned once every day with a disinfectant, and then the dressing should be changed.

Increases the Speed of Healing

There is a myth about the healing of the wounds, that they heal faster when left uncovered, which is not true till any stretch. Instead, a wound heals at a faster pace, when it is properly covered with dressings and medications.

Not only that, proper bandaging of the wound can prevent irritation or infection from taking place

Scarring is Reduced

For halting the formation of scars, the wound should be kept soft, during the healing process. By doing so, you can prevent the hardening of the skin.

Making use of an antibiotic ointment recommended by a medic can help the skin to stay soft during the process of healing.

Coming to a Close

Due to the high rate of trauma cases and injuries, there is a positive impact on the demand for wound care products all over the world. The total value of the industry will reach USD 34,459.2 million, by the end of this decade.

2 novembre 2023

3D Bioprinting – Industry Development and Forecast Report 2030

The 3D bioprinting market will power at a rate of 19.4% in the future, to reach USD 5,873 million by 2030. Living organs can be printed in 3D by layering living cells, which is the reason why bio engineering is progressively significant to human society.

With the growing requirement for bio-engineered organs, investigators have made key progressions in this tech.

Hence, the expansion of 3D biomaterials and bioprinters, their use in the pharma and cosmetics industries, and the surge in private and public financing for bioprinting research actions are persuading the industry positively.

Doctors make use of additive manufacturing for the creation of new bones and organs, and it is a major innovation in healthcare. Also, this allows the printing of prosthetic limbs for replacing missing limbs.

Additionally, as compared to the traditional process, which needs a long time and a donor, 3D bioprinting allows the transplantation to be done at a much faster pace.

The requirement for indispensable body parts for transplantation is enormously high globally. For making the things worse, there is an enormous gap amid the supply and requirement of tissues and organs. Numerous organs, for example the kidneys, lungs, heart, pancreas, liver, and intestines, are desired for transplantation.

Likewise, the requirement for heart valves, corneas, skin, blood vessels, and bones for transplantation is somewhat high. Rates of organ donation are still, while the requirement for tissues and organs is growing.

The inaccessibility of such parts for transplantation has brought about an increase in count of patients on the transplantation waiting list, a main anxiety for healthcare organization and providers.

Download free sample copy of this report: https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market/report-sample

North America held about 40% share in the recent past, because of the tech-progressions, growing R&D activities and improving healthcare infra. Other than that, the increasing expenditure on healthcare, growing elderly population, and growing prevalence of chronic ailments, is powering the requirement for this tech, particularly in the pharma sector.

APAC 3D bioprinting market will grow the fastest, chiefly due to the fact that its large base of consumers, increasing R&D in this field, and support of the government and tax breaks.

Researchers from China have brought about major progressions in this tech, for instance the liquid-inliquid printing process, in which liquid polymers are combined for forming a steady membrane.

They state that the subsequent liquid developments can hold their shape for about 240 hours, before the combining commences. They printed numerous difficult shapes with the use of this novel method, which has also opened the way for tissue printing from living cells.

The high requirement for tissues and organ transplants all over the world has a lot to do with the increasing demand for 3D bioprinting process.

1 novembre 2023

North America Is Dominating Medical Aesthetics Industry

The medical aesthetics market is projected to be worth USD 34,124.0 million by 2030, growing at a CAGR of 12.4%. This would be a result of the increasing development of technologically enhanced and easy-to-use products and the mounting need for aesthetic treatments among people.

Furthermore, the acceptance of non-invasive and minimally invasive aesthetic methods is increasing worldwide due to the loose facial skin, specifically around the jowls, cheeks, and eyes, and dry skin for others, which are some of the significant changes that typically happen when an individual ages. In addition, the need for aesthetic equipment is growing, because of the surging acceptance of cosmetic methods among common people, to look better.

North America held the largest revenue share in recent years and the continent is also projected to be in the leading position to reach USD 15 billion by 2030. This can be credited to innovation in cosmetic practices as a huge number of future key players and established players either have headquarters or have a significant existence in the region.

Get the sample copy of this report: https://www.psmarketresearch.com/market-analysis/medical-aesthetics-market/report-sample

Moreover, the growing investment in the healthcare sector, the governments’ supportive initiatives for inviting foreign investments, and the mounting R&D development via enhanced technologies are contributing to the growth of the regional market.

The APAC medical aesthetics market is projected to grow at a significant rate in the years to come. Developing countries in the region are showing a significant surge in the use of cosmetic treatments, mainly due to the reasons like increasing per capita income of middle-class people, the aging population, the growing awareness about skin problems, and the snowballing number of medical tourists in the region choosing for cosmetic treatments.

In recent years, the injectables category had the largest revenue share of over 40%, this can be ascribed to growing sales of injectables, including dermal fillers, botulinum toxin, and neurotoxins. In addition, the need for injectables is growing because of several factors like short procedure time, minimal scarring, instant result, cost-efficiency of the products, and minimally invasive.

The beauty clinics category holds the largest revenue share of over 50%, mainly because of the increasing per-capita of many countries, and also the snowballing number of beauty centers throughout the world. Such clinics come with several aesthetic treatments, including wrinkle treatment, body enhancement, augmentation, and scar removal. This is why the demand for dermal fillers and neurotoxins in beauty clinics and centers is increasing.

Hence, the Increasing development of technologically enhanced and easy-to-use products and the mounting need for aesthetic treatments among people are the major factors contributing to the growth of the medical aesthetics market.